Fact CheckerSign in

NCT06495138Recruiting

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 23 Oct 2026

Brief summary (registry, in English)

The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
138 (estimated)
First submitted
2 Jul 2024
Start date
21 Apr 2025
Primary completion date
Oct 2027
Lead sponsor
Emory University
NCT number
NCT06495138

What you commit to

  • Study type: Interventional
  • Planned participants: 138
  • From 21 Apr 2025 to the primary completion date, Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Worsening MS symptoms during the prior 60 days
  • Immunotherapy change in the prior 60 days

Other illness

  • Clinically isolated syndrome or radiologically isolated syndrome.
  • Self-reported cognitive impairment that limits independence with basic and instrumental activities of daily living
  • Convergence insufficiency
  • Major orthopedic conditions that limit cervical spine range of motion or that alter walking

Other

  • Systolic blood pressure \> 180 mmHg and/or diastolic blood pressure \> 90 mmHg at rest
  • Static visual acuity with correction of worse than 1.0 logMAR
  • Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus}
  • Intra-nuclear ophthalmoplegia
  • Vestibular Migraine
  • Self-reported current or potential for pregnancy during enrollment
  • Ongoing participation in vestibular rehabilitation for dizziness

Who the study is looking for

  • Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MS per The 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging in MS, or a healthy volunteer without a diagnosis of multiple sclerosis or any related neurological conditions
  • Fluent in speaking and understanding English
  • Subjects with multiple sclerosis have self-reported vestibular symptoms of dizziness, imbalance, and/or a history of at least two falls in the prior 12 months

Age in the registry: 18 years to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emory Univeristy
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.